| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.46T | 1.37T | 1.30T | 1.26T | 1.15T |
| Gross Profit | 250.58B | 204.71B | 188.25B | 161.58B | 184.68B |
| EBITDA | 102.65B | 77.66B | 71.28B | 49.38B | 78.83B |
| Net Income | 35.07B | 26.59B | 28.08B | 19.37B | 36.01B |
Balance Sheet | |||||
| Total Assets | 997.48B | 949.27B | 958.24B | 937.15B | 909.21B |
| Cash, Cash Equivalents and Short-Term Investments | 68.68B | 71.56B | 65.47B | 64.99B | 85.37B |
| Total Debt | 228.55B | 223.90B | 214.85B | 242.06B | 211.41B |
| Total Liabilities | 445.79B | 412.20B | 419.04B | 434.37B | 419.66B |
| Stockholders Equity | 536.94B | 524.29B | 527.50B | 492.91B | 479.07B |
Cash Flow | |||||
| Free Cash Flow | 47.87B | 41.47B | 38.11B | -70.93B | -11.09B |
| Operating Cash Flow | 82.34B | 77.44B | 86.59B | 11.33B | 33.39B |
| Investing Cash Flow | -34.04B | -42.72B | -39.22B | -63.68B | -23.03B |
| Financing Cash Flow | -56.00B | -29.85B | -53.19B | 28.42B | -11.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥1.13T | 15.42 | 13.07% | 1.82% | 5.72% | 13.87% | |
65 Neutral | ¥415.82B | 14.90 | 10.18% | 2.56% | 5.09% | 10.53% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ¥472.76B | 18.06 | 9.86% | 2.58% | 2.00% | 12.21% | |
57 Neutral | ¥260.03B | 19.19 | ― | 2.61% | 8.35% | 54.38% | |
56 Neutral | ¥582.77B | 19.47 | 6.04% | 2.04% | 6.34% | 38.64% | |
53 Neutral | ¥788.67B | 19.10 | 9.77% | 2.41% | 1.49% | -14.54% |